<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">regmedjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Регенерация органов и тканей</journal-title><trans-title-group xml:lang="en"><trans-title>Регенерация органов и тканей</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-5938</issn><publisher><publisher-name>Общество регенеративной медицины</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.60043/2949-5938-2026-2-68-81</article-id><article-id custom-type="elpub" pub-id-type="custom">regmedjournal-153</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Протеомный анализ интерактома белка активации фибробластов альфа (FAPα) в активированных фибробластах человека: идентификация потенциальных партнеров, субстратов и кооперация с интегриновым сигналингом</article-title><trans-title-group xml:lang="en"><trans-title>Proteomic analysis of the fibroblast activation protein alpha (FAPα) interactome in activated human fibroblasts: identification of potential partners, substrates, and cooperation with integrin signaling</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бутузова</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Butuzova</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бутузова Дарья Андреевна — аспирант кафедры биохимии и регенеративной биомедицины Факультета фундаментальной медицины; лаборант-исследователь лаборатории репарации и регенерации тканей Центра регенеративной медицины</p><p>119192, Москва, Ломоносовский пр., 27к10</p></bio><bio xml:lang="en"><p>Daria A. Butuzova — Postgraduate Student, Department of Biochemistry and Regenerative Biomedicine, Faculty of Fundamental Medicine; Research Assistant, Laboratory of Tissue Repair and Regeneration, Center for Regenerative Medicine.</p><p>119192, Moscow Lomonosovsky ave., 27–10</p></bio><email xlink:type="simple">da.butuzova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулебякина</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulebyakina</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кулебякина Мария Александровна — к.б.н., ассистент кафедры биохимии и регенеративной биомедицины Факультета фундаментальной медицины</p><p>119192, Москва, Ломоносовский пр., 27к10</p></bio><bio xml:lang="en"><p>Maria A. Kulebyakina — Cand. Sci. (Biology), Assistant Professor, Department of Biochemistry and Regenerative Biomedicine, Faculty of Fundamental Medicine.</p><p>119192, Moscow Lomonosovsky ave., 27–10</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Басалова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Basalova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Басалова Наталия Андреевна — к.б.н., научный сотрудник лаборатории репарации и регенерации тканей Центра регенеративной  медицины; доцент кафедры биохимии и регенеративной биомедицины Факультета фундаментальной медицины</p><p>119192, Москва, Ломоносовский пр., 27к10</p></bio><bio xml:lang="en"><p>Nataliya A. Basalova — Cand. Sci. (Biology), Research Scientist, Laboratory of Tissue Repair and Regeneration, Center for Regenerative Medicine; Assistant Professor, Department of Biochemistry and Regenerative Biomedicine, Faculty of Fundamental Medicine.</p><p>119192, Moscow Lomonosovsky ave., 27–10</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефименко</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Efimenko</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ефименко Анастасия Юрьевна — д.м.н., доцент, профессор РАН, зав. лабораторией репарации и регенерации тканей Центра регенеративной медицины; доцент кафедры биохимии и регенеративной биомедицины Факультета фундаментальной медицины</p><p>119192, Москва, Ломоносовский пр., 27к10</p></bio><bio xml:lang="en"><p>Anastasia Yu. Efimenko — Dr. Sci. (Medicine), Associate Professor, Professor of the Russian Academy of Sciences, Head of the Laboratory of Tissue Repair and Regeneration, Center for Regenerative Medicine; Associate Professor, Department of Biochemistry and Regenerative Biomedicine, Faculty of Fundamental Medicine.</p><p>119192, Moscow Lomonosovsky ave., 27–10</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский научно-образовательный институт ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Research and Educational Institute, M.V. Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>09</day><month>10</month><year>2026</year></pub-date><volume>4</volume><issue>2</issue><fpage>68</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бутузова Д.А., Кулебякина М.А., Басалова Н.А., Ефименко А.Ю., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Бутузова Д.А., Кулебякина М.А., Басалова Н.А., Ефименко А.Ю.</copyright-holder><copyright-holder xml:lang="en">Butuzova D.A., Kulebyakina M.A., Basalova N.A., Efimenko A.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.regmed-journal.ru/jour/article/view/153">https://www.regmed-journal.ru/jour/article/view/153</self-uri><abstract><p>Введение. Белок активации фибробластов альфа (FAPα) представляет собой трансмембранную сериновую протеазу, экспрессия которой резко возрастает в стромальных клетках при фиброзе и развитии опухолей. Известно, что FAPα участвует в ремоделировании внеклеточного матрикса, однако полный спектр его потенциальных белковых партнеров и ферментативных субстратов в активированных фибробластах остается недостаточно охарактеризованным. Целью настоящей работы явилась идентификация белков, образующих комплексы с FAPα в активированных фибробластах человека, оценка их субстратного статуса и верификация кооперации с интегриновым сигналингом.Материалы и методы. Первичные дермальные фибробласты человека активировали путем обработки TGF-β1 (10 нг/мл, 24 ч). Иммунопреципитацию FAPα проводили с использованием двух независимых антител (Cell Signaling и R&amp;D Systems), специфичность подтверждали вестерн-блоттингом. Белки, элюированные из иммунопреципитатов, осаждали трихлоруксусной кислотой, подвергали трипсинолизу и анализировали методом масс-спектрометрии (Q Exactive Plus). Данные обрабатывали с использованием программных пакетов MaxQuant и Perseus. Функциональную аннотацию идентифицированных белков выполняли с использованием GO Enrichment Analysis. Наличие предполагаемых сайтов расщепления FAPα оценивали биоинформатически. Взаимодействие с интегринами β1, αV и TGFβRII верифицировали методом вестерн-блоттинга.Результаты. Специфичность иммунопреципитации была подтверждена для обоих типов антител. В двух независимых повторностях идентифицировано 47 белков, из которых 16 специфически копреципитировались с FAPα. Функциональная аннотация выявила среди этих белков значимое обогащение пептидазами (химаза, карбоксипептидаза D), ингибиторами протеаз (аннексин А2) и молекулами клеточной адгезии (тенасцин). Анализ сайтов расщепления показал, что только белок ZC3H4 содержит одновременно мотивы GP, PPGP и GPA, тогда как карбоксипептидаза D содержит мотив GPA. Вестерн-блоттинг подтвердил образование комплексов FAPα с интегринами β1 и αV, а также снижение копреципитации TGFβRII после активации клеток.Выводы. В ходе работы идентифицировано 16 потенциальных белков-партнеров FAPα в активированных фибробластах; среди них ZC3H4 является наиболее вероятным прямым субстратом. Экспериментально подтверждена кооперация FAPα с интегринами β1 и αV. Полученные данные расширяют представления о функциональной роли FAPα и создают основу для дальнейшего изучения ее роли в патогенезе фиброза и опухолевой прогрессии.</p></abstract><trans-abstract xml:lang="en"><p>Background. Fibroblast activation protein alpha (FAPα) is a transmembrane serine protease whose expression is markedly upregulated in stromal cells during fibrosis and tumor development. Although FAPα is known to participate in extracellular matrix remodeling, the full repertoire of its potential protein partners and enzymatic substrates in activated fibroblasts remains incompletely characterized. This study aimed to identify proteins that form complexes with FAPα in activated human fibroblasts, to evaluate their substrate status, and to confirm cooperation with integrin signaling.Materials and methods. Primary human dermal fibroblasts were activated by treatment with TGF-β1 (10 ng/mL, 24 h). Immunoprecipitation of FAPα was performed using two independent antibodies (Cell Signaling and R&amp;D Systems), and specificity was confirmed by Western blotting. Proteins eluted from immunoprecipitates were precipitated with trichloroacetic acid, subjected to trypsin digestion, and analyzed by mass spectrometry on a Q Exactive Plus instrument. Data were processed using the MaxQuant and Perseus software suites. Functional annotation of identified proteins was carried out using GO Enrichment Analysis. The presence of putative FAPα cleavage sites was assessed bioinformatically. Interactions with integrins β1, αV, and TGFβRII were verified by Western blotting.Results. Immunoprecipitation specificity was confirmed for both antibody types. In two independent replicates, a total of 47 proteins were identified, of which 16 specifically co-precipitated with FAPα. Functional annotation revealed significant enrichment among these proteins for peptidases (chymase, carboxypeptidase D), protease inhibitors (annexin A2), and cell adhesion molecules (tenascin). Cleavage site analysis demonstrated that only ZC3H4 simultaneously contains GP, PPGP, and GPA motifs, whereas carboxypeptidase D contains only the GPA motif. Western blotting confirmed the formation of complexes between FAPα and integrins β1 and αV, as well as reduced co-precipitation of TGFβRII following cell activation.Conclusions. In this study, we identified 16 potential protein partners of FAPα in activated fibroblasts, among which ZC3H4 emerges as the most likely direct substrate. Cooperation between FAPα and integrins β1 and αV was experimentally confirmed. Collectively, these findings expand our understanding of the functional role of FAPα and provide a foundation for further investigation into its contribution to the pathogenesis of fibrosis and tumor progression.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>белок активации фибробластов альфа (FAPα)</kwd><kwd>фибробласты</kwd><kwd>TGF-β1</kwd><kwd>протеомный анализ</kwd><kwd>белки-партнеры</kwd><kwd>субстраты FAPα</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fibroblast activation protein alpha (FAPα)</kwd><kwd>fibroblasts</kwd><kwd>TGF-β1</kwd><kwd>proteomic analysis</kwd><kwd>protein partners</kwd><kwd>FAPα substrates</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">исследование выполнено за счет гранта Российского научного фонда №23-15-00198-П, https://rscf.ru/project/23-15-00198-П/. Оборудование, использованное в исследовании, было приобретено в рамках Программы развития МГУ имени М.В. Ломоносова и государственного задания МГУ имени М.В. Ломоносова. Авторы выражают благодарность к.б.н. О.А. Григорьевой (МГУ имени М.В. Ломоносова) и к.б.н. О.И. Клычникову (МГУ имени М.В. Ломоносова) за участие в критическом обсуждении методических подходов и результатов эксперимента.</funding-statement><funding-statement xml:lang="en">The study was supported by the Russian Science Foundation project no. 23-15-00198-P, https://rscf.ru/en/project/23-15-00198-П/. Equipment used for the study was purchased as a part of Lomonosov MSU Program of Development and Lomonosov MSU State Assignment. The authors thank O.A. Grigorieva, Ph.D. (Lomonosov Moscow State University) and O.I. Klychnikov, Ph.D. (Lomonosov Moscow State University) for participating in a critical discussion of methodological approaches and experimental results.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang XL, Xiao W, Qian JP, Yang WJ, Xu H, Xu X da, et al. The Role and Application of Fibroblast Activating Protein. Curr Mol Med. 2024;24(9):1097–1110. DOI: 10.2174/1566524023666230530095305. PubMed PMID: 37259211.</mixed-citation><mixed-citation xml:lang="en">Zhang XL, Xiao W, Qian JP, Yang WJ, Xu H, Xu X da, et al. The Role and Application of Fibroblast Activating Protein. Curr Mol Med. 2024;24(9):1097–1110. DOI: 10.2174/1566524023666230530095305. PubMed PMID: 37259211.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Butuzova DA, Kulebyakina MA, Basalova NA, Efimenko AYu. Fibroblast Activation Protein Alpha (FAPα) as a Promising Target in the Diagnostics and Treatment of Cancer and Fibrotic Diseases: Recent Approaches to Imaging and Assessment of Functional Activity. Biochemistry Moscow. 2025 Feb;90(S1):S135–145. DOI: 10.1134/S000629792460279X</mixed-citation><mixed-citation xml:lang="en">Butuzova DA, Kulebyakina MA, Basalova NA, Efimenko AYu. Fibroblast Activation Protein Alpha (FAPα) as a Promising Target in the Diagnostics and Treatment of Cancer and Fibrotic Diseases: Recent Approaches to Imaging and Assessment of Functional Activity. Biochemistry Moscow. 2025 Feb;90(S1):S135–145. DOI: 10.1134/S000629792460279X</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly T, Huang Y, Simms AE, Mazur A. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int Rev Cell Mol Biol. 2012;297:83–116. DOI: 10.1016/B978-0-12-394308-8.00003-0. PubMed PMID: 22608558.</mixed-citation><mixed-citation xml:lang="en">Kelly T, Huang Y, Simms AE, Mazur A. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int Rev Cell Mol Biol. 2012;297:83–116. DOI: 10.1016/B978-0-12-394308-8.00003-0. PubMed PMID: 22608558.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Basalova N, Alexandrushkina N, Grigorieva O, Kulebyakina M, Efimenko A. Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells? Biomolecules. 2023 Nov 29;13(12):1718. DOI: 10.3390/biom13121718</mixed-citation><mixed-citation xml:lang="en">Basalova N, Alexandrushkina N, Grigorieva O, Kulebyakina M, Efimenko A. Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells? Biomolecules. 2023 Nov 29;13(12):1718. DOI: 10.3390/biom13121718</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen WT. The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices. Cancer Research. 2006 May 1;66(9):4652–4661. DOI: 10.1158/0008-5472.CAN-05-1245</mixed-citation><mixed-citation xml:lang="en">Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen WT. The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices. Cancer Research. 2006 May 1;66(9):4652–4661. DOI: 10.1158/0008-5472.CAN-05-1245</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Basalova NA, Vigovskiy MA, Popov VS, Lagereva EA, Grigorieva OA, Efimenko AY. The Role of Activated Stromal Cells in Fibrotic Foci Formation and Reversion. Cells. 2024 Dec 13;13(24):2064. DOI: 10.3390/cells13242064</mixed-citation><mixed-citation xml:lang="en">Basalova NA, Vigovskiy MA, Popov VS, Lagereva EA, Grigorieva OA, Efimenko AY. The Role of Activated Stromal Cells in Fibrotic Foci Formation and Reversion. Cells. 2024 Dec 13;13(24):2064. DOI: 10.3390/cells13242064</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Edosada CY, Quan C, Wiesmann C, Tran T, Sutherlin D, Reynolds M, et al. Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity. Journal of Biological Chemistry. 2006 Mar 17;281(11):7437–7444. DOI: 10.1074/jbc.M511112200</mixed-citation><mixed-citation xml:lang="en">Edosada CY, Quan C, Wiesmann C, Tran T, Sutherlin D, Reynolds M, et al. Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity. Journal of Biological Chemistry. 2006 Mar 17;281(11):7437–7444. DOI: 10.1074/jbc.M511112200</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal S, Brennen WN, Kole TP, Schneider E, Topaloglu O, Yates M, et al. Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry. 2008 Jan 22;47(3):1076–1086. DOI: 10.1021/bi701921b. PubMed PMID: 18095711. PubMed Central PMCID: PMC4696028.</mixed-citation><mixed-citation xml:lang="en">Aggarwal S, Brennen WN, Kole TP, Schneider E, Topaloglu O, Yates M, et al. Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry. 2008 Jan 22;47(3):1076–1086. DOI: 10.1021/bi701921b. PubMed PMID: 18095711. PubMed Central PMCID: PMC4696028.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mori N, Jin J, Krishnamachary B, Mironchik Y, Wildes F, Vesuna F, et al. Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells. Front Oncol. 2023;13:1068405. DOI: 10.3389/fonc.2023.1068405. PubMed PMID: 36937451. PubMed Central PMCID: PMC10015381.</mixed-citation><mixed-citation xml:lang="en">Mori N, Jin J, Krishnamachary B, Mironchik Y, Wildes F, Vesuna F, et al. Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells. Front Oncol. 2023;13:1068405. DOI: 10.3389/fonc.2023.1068405. PubMed PMID: 36937451. PubMed Central PMCID: PMC10015381.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Xin L, Gao J, Zheng Z, Chen Y, Lv S, Zhao Z, et al. Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Front Oncol. 2021 Aug 19;11:648187. DOI: 10.3389/fonc.2021.648187</mixed-citation><mixed-citation xml:lang="en">Xin L, Gao J, Zheng Z, Chen Y, Lv S, Zhao Z, et al. Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Front Oncol. 2021 Aug 19;11:648187. DOI: 10.3389/fonc.2021.648187</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Guan C, Cheng N, Tong Y, Li Y, Liu J, Luo H, et al. Targeting the FAPα/Integrin αvβ1 complex attenuates hepatic stellate cell activation and liver fibrosis. Biochem Pharmacol. 2026 May;247:117801. DOI: 10.1016/j.bcp.2026.117801. PubMed PMID: 41687828.</mixed-citation><mixed-citation xml:lang="en">Guan C, Cheng N, Tong Y, Li Y, Liu J, Luo H, et al. Targeting the FAPα/Integrin αvβ1 complex attenuates hepatic stellate cell activation and liver fibrosis. Biochem Pharmacol. 2026 May;247:117801. DOI: 10.1016/j.bcp.2026.117801. PubMed PMID: 41687828.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tolstoluzhinskaya AE, Basalova NA, Karagyaur MN, Efimenko AY. Tissue-specific expression and alternative splicing of fibroblast activation protein alpha (FAPα) gene in human stromal cells. Genes &amp; Cells. 2025 Apr 7;20(1):54–67. DOI: 10.17816/gc636876</mixed-citation><mixed-citation xml:lang="en">Tolstoluzhinskaya AE, Basalova NA, Karagyaur MN, Efimenko AY. Tissue-specific expression and alternative splicing of fibroblast activation protein alpha (FAPα) gene in human stromal cells. Genes &amp; Cells. 2025 Apr 7;20(1):54–67. DOI: 10.17816/gc636876</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. DOI: 10.1038/227680a0. PubMed PMID: 5432063.</mixed-citation><mixed-citation xml:lang="en">Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. DOI: 10.1038/227680a0. PubMed PMID: 5432063.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nowacki FC, Swain MT, Klychnikov OI, Niazi U, Ivens A, Quintana JF, et al. Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni. J Extracell Vesicles. 2015;4:28665. DOI: 10.3402/jev.v4.28665. PubMed PMID: 26443722. PubMed Central PMCID: PMC4595467.</mixed-citation><mixed-citation xml:lang="en">Nowacki FC, Swain MT, Klychnikov OI, Niazi U, Ivens A, Quintana JF, et al. Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni. J Extracell Vesicles. 2015;4:28665. DOI: 10.3402/jev.v4.28665. PubMed PMID: 26443722. PubMed Central PMCID: PMC4595467.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008 Dec;26(12):1367–1372. DOI: 10.1038/nbt.1511. PubMed PMID: 19029910.</mixed-citation><mixed-citation xml:lang="en">Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008 Dec;26(12):1367–1372. DOI: 10.1038/nbt.1511. PubMed PMID: 19029910.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016 Sep;13(9):731–740. DOI: 10.1038/nmeth.3901. PubMed PMID: 27348712.</mixed-citation><mixed-citation xml:lang="en">Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016 Sep;13(9):731–740. DOI: 10.1038/nmeth.3901. PubMed PMID: 27348712.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">ю Schaab C, Geiger T, Stoehr G, Cox J, Mann M. Analysis of high accuracy, quantitative proteomics data in the MaxQB database. Mol Cell Proteomics. 2012 Mar;11(3):M111.014068. DOI: 10.1074/mcp.M111.014068. PubMed PMID: 22301388. PubMed Central PMCID: PMC3316731.</mixed-citation><mixed-citation xml:lang="en">ю Schaab C, Geiger T, Stoehr G, Cox J, Mann M. Analysis of high accuracy, quantitative proteomics data in the MaxQB database. Mol Cell Proteomics. 2012 Mar;11(3):M111.014068. DOI: 10.1074/mcp.M111.014068. PubMed PMID: 22301388. PubMed Central PMCID: PMC3316731.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou L, Mi H. PANTHER : Making genome-scale phylogenetics accessible to all. Protein Science. 2022 Jan;31(1):8–22. DOI: 10.1002/pro.4218</mixed-citation><mixed-citation xml:lang="en">Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou L, Mi H. PANTHER : Making genome-scale phylogenetics accessible to all. Protein Science. 2022 Jan;31(1):8–22. DOI: 10.1002/pro.4218</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Juillerat-Jeanneret L, Tafelmeyer P, Golshayan D. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Expert Opinion on Therapeutic Targets. 2017 Oct 3;21(10):977–991. DOI: 10.1080/14728222.2017.1370455. PubMed PMID: 28829211.</mixed-citation><mixed-citation xml:lang="en">Juillerat-Jeanneret L, Tafelmeyer P, Golshayan D. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Expert Opinion on Therapeutic Targets. 2017 Oct 3;21(10):977–991. DOI: 10.1080/14728222.2017.1370455. PubMed PMID: 28829211.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020 Sep 1;39(3):783–803. DOI: 10.1007/s10555-020-09909-3</mixed-citation><mixed-citation xml:lang="en">Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020 Sep 1;39(3):783–803. DOI: 10.1007/s10555-020-09909-3</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Imanaka-Yoshida K, Hiroe M, Yoshida T. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Histopathol. 2004 Apr;19(2):517–525. DOI: 10.14670/HH-19.517. PubMed PMID: 15024713.</mixed-citation><mixed-citation xml:lang="en">Imanaka-Yoshida K, Hiroe M, Yoshida T. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Histopathol. 2004 Apr;19(2):517–525. DOI: 10.14670/HH-19.517. PubMed PMID: 15024713.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Ye Y, Peng K, Zeng Z, Chen L, Zeng Y. Histones: The critical players in innate immunity. Front Immunol. 2022 Nov 21;13:1030610. DOI: 10.3389/fimmu.2022.1030610. PubMed PMID: 36479112. PubMed Central PMCID: PMC9720293.</mixed-citation><mixed-citation xml:lang="en">Li X, Ye Y, Peng K, Zeng Z, Chen L, Zeng Y. Histones: The critical players in innate immunity. Front Immunol. 2022 Nov 21;13:1030610. DOI: 10.3389/fimmu.2022.1030610. PubMed PMID: 36479112. PubMed Central PMCID: PMC9720293.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Roos J, Zinngrebe J, Huber-Lang M, Lupu L, Schmidt MA, Strobel H, et al. Trauma-associated extracellular histones mediate inflammation via a MYD88-IRAK1-ERK signaling axis and induce lytic cell death in human adipocytes. Cell Death Dis. 2024 Apr 23;15(4):285. DOI: 10.1038/s41419-024-06676-9</mixed-citation><mixed-citation xml:lang="en">Roos J, Zinngrebe J, Huber-Lang M, Lupu L, Schmidt MA, Strobel H, et al. Trauma-associated extracellular histones mediate inflammation via a MYD88-IRAK1-ERK signaling axis and induce lytic cell death in human adipocytes. Cell Death Dis. 2024 Apr 23;15(4):285. DOI: 10.1038/s41419-024-06676-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition. Mol Cell Biol. 2004 Sep;24(17):7654–7668. DOI: 10.1128/MCB.24.17.7654-7668.2004. PubMed PMID: 15314173. PubMed Central PMCID: PMC506971.</mixed-citation><mixed-citation xml:lang="en">Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition. Mol Cell Biol. 2004 Sep;24(17):7654–7668. DOI: 10.1128/MCB.24.17.7654-7668.2004. PubMed PMID: 15314173. PubMed Central PMCID: PMC506971.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang HE, Hamson EJ, Koczorowska MM, Tholen S, Chowdhury S, Bailey CG, et al. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics. Molecular &amp; Cellular Proteomics. 2019 Jan;18(1):65–85. DOI: 10.1074/mcp.RA118.001046</mixed-citation><mixed-citation xml:lang="en">Zhang HE, Hamson EJ, Koczorowska MM, Tholen S, Chowdhury S, Bailey CG, et al. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics. Molecular &amp; Cellular Proteomics. 2019 Jan;18(1):65–85. DOI: 10.1074/mcp.RA118.001046</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Heldin CH, Moustakas A. Signaling Receptors for TGF-β Family Members. Cold Spring Harb Perspect Biol. 2016 Aug 1;8(8):a022053. DOI: 10.1101/cshperspect.a022053. PubMed PMID: 27481709. PubMed Central PMCID: PMC4968163.</mixed-citation><mixed-citation xml:lang="en">Heldin CH, Moustakas A. Signaling Receptors for TGF-β Family Members. Cold Spring Harb Perspect Biol. 2016 Aug 1;8(8):a022053. DOI: 10.1101/cshperspect.a022053. PubMed PMID: 27481709. PubMed Central PMCID: PMC4968163.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Han Z, Ma Y, Cao G, Ma Z, Chen R, Cvijic ME, et al. Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells. Biochem J. 2021 May 14;478(9):1689–1703. DOI: 10.1042/BCJ20200749. PubMed PMID: 33876829.</mixed-citation><mixed-citation xml:lang="en">Han Z, Ma Y, Cao G, Ma Z, Chen R, Cvijic ME, et al. Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells. Biochem J. 2021 May 14;478(9):1689–1703. DOI: 10.1042/BCJ20200749. PubMed PMID: 33876829.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
